HOUSTON, TX, Feb. 02, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today highlighted Nexalin’s rigorous peer-reviewed clinical research validating its proprietary neurostimulation
Mind and body movement shown to cut dementia risk
When it comes to staying sharper longer, a Massachusetts expert said it’s about much more than getting physical exercise. Dr. Peter Wayne, director of the Osher Center for Integrative Health at Mass General Brigham, said practices like Tai Chi have …
